Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Completed · Phase 2

Conditions studied: Attention Deficit Disorder With Hyperactivity

In brief

Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone

Key facts

Study ID

NCT00174226

Run by

Pfizer

People needed

241

Starts

2004-11-01

Expected to finish

2006-01-01

Last updated by the study team

2008-07-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with ADHD

You may not qualify if…

• Other Axis I Psychiatric Disorders

Where it is running

• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Durham, North Carolina, United States
• Pfizer Investigational Site — Durham, North Carolina, United States
• Pfizer Investigational Site — Salt Lake City, Utah, United States
• Pfizer Investigational Site — Woodstock, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.